An adult male undergoing chemotherapy for RCC ;the drug used inhibits tyrosine kinases that are necessary for tumor cell growth and angiogenesis .HTN ;rash and fatigue are adverse effects associated with this drug. additinally this drug shudnt b given with doxorubin .Which of the following is the most likely therapeutic agent in this case?
a] etoposide
b] flutamide
c] imatinib
d] leuprolide
e] sorafenib
Sent by: DR. KAPIL
Subscribe to:
Post Comments (Atom)
Posts
1 comment:
E. sorafenib
(sorafenib & sunitinib are indicated for renal cell carcinoma & r tyrosine kinase inhibitors)
Post a Comment